Skip to main content
SpringerLink
Log in

Malignancy

  • Chapter
HLA and Disease Associations

Abstract

There was no indication of any association of the A and B loci antigens in 40 Czechoslovakian patients and 301 controls.1 However, a highly significant association with DR1 has been reported by Panza et al.2(Table 12.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Majsky VA, Feix C, Nemec J: Thyroid carcinoma and HLA-system. Z Gesamte Inn Med 33:797–798, 1978.

    PubMed  CAS  Google Scholar 

  2. Panza N, Del Vecchio L, Maio M, De Felice M, Lombardi G, Minozzi M, et al: Strong association between HLA-DR antigen and thyroid carcinoma. Tissue Antigens 20:155–158, 1982

    PubMed  CAS  Google Scholar 

  3. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  4. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  5. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  6. Hirschberg H, Endresen L, Wikeby P: Histocompatibility antigens on astrocytoma cells. J Neurol Neurosurg Psychiatry 45:193–198, 1982

    PubMed  CAS  Google Scholar 

  7. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  8. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  9. Braf ZF, Gazit E, Many M: HLA-A and HLA-B antigens in transitional cell carcinoma of the bladder. J Urol 122:465–466, 1979

    PubMed  CAS  Google Scholar 

  10. Arce S, Lopez R, Almaguer M, Ballester JM, Filgueiras E, Vstariz C, et al.: HL-A antigens and transitional-cell carcinoma of the bladder. Mater Med Pol 10:98–100, 1978

    PubMed  CAS  Google Scholar 

  11. Obata K, Ohno Y, Murase T, Aoki K, Tsuji K: Bladder cancer and HLA antigens. Nagoya J Med Sci 43:65–70, 1981

    PubMed  CAS  Google Scholar 

  12. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  13. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, and Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  14. Barry JM, Goldstein A, Hubbard M: Human leukocyte A and B antigens in patients with prostatic adenocarcinoma. J Urol 124:847–848, 1980

    PubMed  CAS  Google Scholar 

  15. Feingold N, Degos L, Feingold J: HLA in populations: An approach for genetical susceptibility to cancer. J Immunogenet 6:29–35, 1979

    PubMed  CAS  Google Scholar 

  16. Claas FHJ, Van Steenbrugge GJ: Expression of HLA-like structures on a permanent human tumor line PC-93. Tissue Antigens 21:227–232, 1983

    PubMed  CAS  Google Scholar 

  17. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  18. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, and Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  19. Bertrams J, Thraenhart O, Feldmann U, Kuweit E: HL-A antigens in carcinoma of the breast, ovarium, cervix and endometrium: Possible association of haplotype HL-A10-W18 with carcinoma of the breast. Z Krebsforsch 83:219–222, 1975

    CAS  Google Scholar 

  20. Tsuji K, Ito M, Miyamoto H, Yamashita H: HL-A antigenic loss in a cancer patient—A case report. Gan 63:495–497, 1972

    PubMed  CAS  Google Scholar 

  21. Twomey PL, Rogentine GN, Chretien PB: Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. Int Surg 59:468–472, 1974

    PubMed  CAS  Google Scholar 

  22. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  23. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  24. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  25. Bertrams J, Thraenhart O, Feldmann U, Kuwert E: HL-A antigens in carcinoma of the breast, ovarium, cervix and endometrium: Possible association of haplotype HL-A10-W18 with carcinoma of the breast. Z Krebsforsch 83:219–222, 1975

    CAS  Google Scholar 

  26. Sniecinski I, Haley J, Morgan-Byrne J, Van Nagell J Jr: Histocompatibility-antigen distribution in patients with cervical endometrial carcinomas. Gynecol Oncol 11:68–74, 1981

    PubMed  CAS  Google Scholar 

  27. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Raven Press, New York, 1977, p 321

    Google Scholar 

  28. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  29. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  30. Twomey PL, Rogentine GN, Chretien PB: Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. Int Surg 59:468–472, 1974

    PubMed  CAS  Google Scholar 

  31. Sniecinski I, Haley J, Morgan-Byrne J, Van Nagell J Jr: Histocompatibility-antigen distribution in patients with cervical endometrial carcinomas. Gynecol Oncol 11:68–74, 1981

    PubMed  CAS  Google Scholar 

  32. Bertrams J, Thraenhart O, Feldman U, Kuwert E: HL-A antigens in cancer of the breast and the Collum uteri. Z Immun Forsch 148:391–394, 1975

    Google Scholar 

  33. Bertrams J, Thraenhart O, Feldmann U, Kuweit E: HL-A antigens in carcinoma of the breast, ovarium, cervix and endometrium: Possible association of haplotype HL-A10-W18 with carcinoma of the breast. Z Krebsforsch 83:219–222, 1975

    CAS  Google Scholar 

  34. Hammond MG, Appadoo B, Brain P: HLA and cancer in South African Indians. Tissue Antigens 14:296–302, 1979

    PubMed  CAS  Google Scholar 

  35. Hammond MG, Appadoo B, Brain P: HLA and cancer in South African negroes. Tissue Antigens 9:1–7, 1977

    PubMed  CAS  Google Scholar 

  36. Koenig UD, Muller N, Schneweis KE: Herpes-simplex-type-2 antibodies and HLA-B12 in cervical cancer. Lancet ii:857, 1976

    Google Scholar 

  37. Koenig UD, Muller N: Zur Wertigeit der Untersuchungen von HL-A Antigenen und lymphozytotox-ischen Antiporperm bei Cervixcarcinom-Apatientinnen. Arch Gynaekol 224:473–474, 1977

    CAS  Google Scholar 

  38. Koenig UD, Muller N: Untersuchungen zur Bedeutung der Histokompatibilitatsantigene bei Zervixkar-zinompatientinnen. Geburtshilfe Frauenheilkd 36:416–420, 1976

    PubMed  CAS  Google Scholar 

  39. Truia CI, Truia M, Iosub A, Mudric V, Costachel O: Variation of the HL-A antigens during neoplasm evolution. Physiologie 17:239–245, 1980

    PubMed  CAS  Google Scholar 

  40. Patel R, Habal MB, Wilson RE, Birtch AG, Moore FD: Histocompatibility (HL-A) antigens and cancer of the breast: Association with HL-A7. Am J Surg 124:31–34, 1972

    PubMed  CAS  Google Scholar 

  41. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  42. Martz E, Benacerraf B: Lack of association between carcinoma of the breast and HL-A specificities. Tissue Antigens 3:30–38, 1973

    PubMed  CAS  Google Scholar 

  43. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  44. De Jong-Bakker M, Cleton FJ, D’Amaro J, Keuning JJ, Van Rood JJ: HL-A antigens and breast cancer. Eur J Cancer 10:555–558, 1974

    PubMed  Google Scholar 

  45. Bouillenne C, Deneufbourg JM: Positive correlation between breast cancer incidence and HLA antigens. Oncology 36:156–159, 1979

    PubMed  CAS  Google Scholar 

  46. Cordon AL, James DCO: HL-A and carcinoma of the breast. Lancet ii:565, 1973

    Google Scholar 

  47. Bertrams J, Thraenhart O, Feldman U, Kuweit E: HL-A antigens in cancer of the breast and the Collum uteri. Z Immun Forsch 148:391–394, 1975

    Google Scholar 

  48. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  49. Hammond MG, Appadoo B, Brain P: HLA and cancer in South African negroes. Tissue Antigens 9:1–7, 1977

    PubMed  CAS  Google Scholar 

  50. Hammond MG, Appadoo B, Brain P: HLA and cancer in South African Indians. Tissue Antigens 14:296–302, 1979

    PubMed  CAS  Google Scholar 

  51. Feingold N, Degos L, Feingold J: HLA in populations: An approach for genetical susceptibility to cancer. J Immunogenet 6:29–35, 1979

    PubMed  CAS  Google Scholar 

  52. Hors J, Dausset J: Maladies malignes identiques au sein d’une même famille. Nouv Presse Med 3:1237, 1974

    PubMed  CAS  Google Scholar 

  53. Bertrams J, Thraenhart O, Feldmann U, Kuweit E: HL-A antigens in carcinoma of the breast, ovarium, cervix and endometrium: Possible association of haplotype HL-A10-W18 with carcinoma of the breast. Z Krebsforsch 83:219–222, 1975

    CAS  Google Scholar 

  54. Noulinier J, Hoerni B, Durand M, Chauvergne J: Antigenes HL-A et cancer du sein. Nouv Presse Med 2:1072, 1973

    Google Scholar 

  55. Fleming KA, McMichael A, Morton JA, Woods, J, McGee JOD: Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol 34:779–784, 1981

    PubMed  CAS  Google Scholar 

  56. Truia CI, Truia M, Iosub A, Mudric V, Costachel O: Variation of the HL-A antigens during neoplasm evolution. Physiologie 17:239–245, 1980

    PubMed  CAS  Google Scholar 

  57. Natali PG, Giacomini P, Bigotti A, Imai K, Nicotra MR, Ng AK, et al: Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res 43:660–668, 1983

    PubMed  CAS  Google Scholar 

  58. Hammond MG, Appadoo B, Brain P: HLA and cancer in South African negroes. Tissue Antigens 9:1–7, 1977

    PubMed  CAS  Google Scholar 

  59. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  60. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  61. Markman M, Braine HG, Bias WB, Abeloff MD: Association between HLA-Bw44 and small-cell carcinoma of the lung. N Engl J Med 307:1087, 1982

    PubMed  CAS  Google Scholar 

  62. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  63. Tongio MM, Kerschen C, Pauli G, Roeslin N, Grange D, Mayer S: HLA antigens and primary bronchial carcinoma. Cancer 49:2485–2488, 1982

    PubMed  CAS  Google Scholar 

  64. Dellon AL, Rogentine GN, Chretien PB: Prolonged survival in bronchogenic carcinoma associated with HLA antigens W-19 and HL-A5: A preliminary report. J Natl Cancer Inst 54:1283–1286, 1975

    PubMed  CAS  Google Scholar 

  65. Rogentine GN Jr, Dellon AL, Chretien PB: Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-AW19 and HLA-B5. Cancer 39:2345–2347, 1977

    PubMed  Google Scholar 

  66. Sengar DPS, McLeish WA, Stewart THM, Harris JE: HLA antigens in bronchogenic carcinoma. Oncology 34:143–145, 1977

    PubMed  CAS  Google Scholar 

  67. Sengar DPS, McLeish WA, Stewart THM, Harris JE: HLA-Antigene beim Bronchuskarzinom. Onkologie 1:63–65, 1978

    PubMed  CAS  Google Scholar 

  68. Weiss GB, Nawrocki LB, Daniels JC: HLA type and survival in lung cancer. Cancer 46:38–40, 1980

    PubMed  CAS  Google Scholar 

  69. Feingold N, Degos L, Feingold J: HLA in populations: An approach for genetical susceptibility to cancer. J Immunogenet 6:29–35, 1979

    PubMed  CAS  Google Scholar 

  70. Truia CI, Truia M, Iosub A, Mudric V, Costachel O: Variation of the HL-A antigens during neoplasm evolution. Physiologie 17:239–245, 1980

    PubMed  CAS  Google Scholar 

  71. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  72. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  73. Deneufbourg JM, Bouillenne C: Relationship of HLA antigens to larynx carcinoma: Incidence and five-year survival. Bull Cancer (Paris) 67:531–534, 1980

    CAS  Google Scholar 

  74. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  75. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  76. Zervas J, Karvountzis G, Theodoropoulos G: HLA antigens and hepatocellular carcinoma. Gastroenterology 79:601, 1980

    PubMed  CAS  Google Scholar 

  77. Hammond MG, Appadoo B, Brain P: HLA and cancer in South African negroes. Tissue Antigens 9:1–7, 1977

    PubMed  CAS  Google Scholar 

  78. Kew MC, Gear AJ, Baumgarten I, Dusheiko GM, Maier G: Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients. Gastroenterology 77:537–539, 1979

    PubMed  CAS  Google Scholar 

  79. Chan SH, Simons MJ, Oon CJ: HLA antigen in Chinese patients with hepatocellular carcinomas. J Natl Cancer Inst 65: 21–23, 1980

    PubMed  CAS  Google Scholar 

  80. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  81. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  82. Alcalay M, Bontoux D, Maire P, Matuchansky C, Alcalay D, Tänzer J: HLA-B27 and colorectal cancer. N Engl J Med 307:443–444, 1982

    PubMed  CAS  Google Scholar 

  83. Feingold N, Degos L, Feingold J: HLA in populations: An approach for genetical susceptibility to cancer. J Immunogenet 6:29–35, 1979

    PubMed  CAS  Google Scholar 

  84. Hiwatashi N, Kikuchi T, Masamune O, Ouchi E, Watanabe H, Goto Y: HLA antigens in colorectal cancers and adenomas. Tohoku J Exp Med 131:257–260, 1980

    PubMed  CAS  Google Scholar 

  85. Daar AS, Fuggle SV, Ting A, Fabre JW: Anomolous expression of HLA-DR antigens on human colorectal cancer cells. J Immunol 129:447–449, 1982

    PubMed  CAS  Google Scholar 

  86. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr, (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  87. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  88. Hiwatashi N, Kikuchi T, Masamune O, Ouchi E, Watanabe H, Goto Y: HLA antigens in colorectal cancers and adenomas. Tohoku J Exp Med 131:257–260, 1980

    PubMed  CAS  Google Scholar 

  89. Feingold N, Degos L, Feingold J: HLA in populations: An approach for genetical susceptibility to cancer. J Immunogenet 6:29–35, 1979

    PubMed  CAS  Google Scholar 

  90. Sivak MV, Sivak DS, Braun WA, Sullivan BH: A linkage study of HLA and inherited adenocarcinoma of the colon. Cancer 48:76–81, 1981

    PubMed  Google Scholar 

  91. Daar AS, Fuggle SV, Ting A, Fabre JW: Anomolous expression of HLA-DR antigens on human colorectal cancer cells. J Immunol 129:447–449, 1982

    PubMed  CAS  Google Scholar 

  92. Alcalay M, Bontoux D, Maire P, Matuchansky C, Alcalay D, Tänzer J: HLA-B27 and colorectal cancer. N Engl J Med 307:443–444, 1982

    PubMed  CAS  Google Scholar 

  93. Tsuji K, Miyamoto H, Motoaki I. HL-A and its clinical application. Keio J Med 21:159–169, 1972

    PubMed  CAS  Google Scholar 

  94. Terasaki PI, Perdue ST, and Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr, (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  95. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  96. Nomura A, Glober GA, Terasaki PI, Stemmermann GN: HLA antigens in stomach cancer. Int J Cancer 25:195–196, 1980

    PubMed  CAS  Google Scholar 

  97. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  98. Terasaki PI, Perdue ST, and Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr, (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p. 321

    Google Scholar 

  99. Hammond MG, Appadoo B, Brain P: HLA and cancer in South African negroes. Tissue Antigens 9:1–7, 1977

    PubMed  CAS  Google Scholar 

  100. Hammond MG, Angorn B: HLA and cancer of the esophagus in South African Negroes. Tissue Antigens 16:254–255, 1980

    PubMed  CAS  Google Scholar 

  101. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  102. Simons MJ, Wee GB, Chan SH, Shanmugaratnam K, Day NE, De-The GB: Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet i: 142–143, 1975

    Google Scholar 

  103. Simons MJ, Day NE: Histocompatibility leukocyte antigen patterns and nasopharyngeal carcinoma. Natl Cancer Inst Monogr 47:143–146, 1977

    PubMed  CAS  Google Scholar 

  104. Simons MJ, Wee GB, Singh D, Dharmalingham S, Yong NK, Chau JCW, et al: Immunogenetic aspects of nasopharyngeal carcinoma. V. Confirmation of a Chinese-related HLA profile (A2, Singapore 2). Natl Cancer Inst Monogr 47:147–151, 1977

    PubMed  CAS  Google Scholar 

  105. Simons MJ, Wee GB, Goh EH, Chan SH, et al: Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2 Sin 2). J Natl Cancer Inst 57:977–980, 1976

    PubMed  CAS  Google Scholar 

  106. Betuel H, Camoun M, Colombani J, Day NE, Ellouz R, De-The G: The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians. Int J Cancer 16:249–254, 1975

    PubMed  CAS  Google Scholar 

  107. Jing J, Louie E, Henderson BE, Terasaki PI: Histocompatibility leukocyte antigen patterns in nasopharyngeal carcinoma cases from California. Natl Cancer Inst Monogr 47:153–156, 1977

    PubMed  CAS  Google Scholar 

  108. Lanier A, Bender T, Talbot M, Wilmeth S, Tschopp C, Henle W, et al: Nasopharyngeal carcinoma in Alaskan Eskimos, Indians, and Aleuts. Cancer 46:2100–2106, 1980

    PubMed  CAS  Google Scholar 

  109. Joncas JH, Rioux E, Wastiaux JP, Leyritz M, Robillard L, Menezes J: Nasopharyngeal carcinoma and Burkitt’s lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins. Can Med Assoc J 115:858–860, 1976

    PubMed  CAS  Google Scholar 

  110. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  111. Farid NR, Noel EP, Sampson L, Russell NA: Prolactin secreting pituitary adenomata are possibly associated with HLA-B8. Tissue Antigens 15:333–335, 1980

    PubMed  CAS  Google Scholar 

  112. Can BI, Bach FH: Possible association between HLA-AW24 and metastatic testicular germ cell tumours. Lancet i:1346–1347, 1979

    Google Scholar 

  113. Pollack MS, Vugrin D, Hennessy W, Herr HW, Dupont B, Whitmore WF Jr: HLA antigens in patients with germ cell cancers of the testis. Cancer Res 42:2470–2473, 1982

    PubMed  CAS  Google Scholar 

  114. Majsky A, Abrahamova J, Korinkova P, Bek V: HLA system and testicular germinative tumours. Oncology 36:228–231, 1979

    PubMed  CAS  Google Scholar 

  115. DeWolf WC, Lange PH, Einarson ME, Yunis EJ: HLA and testicular cancer. Nature 277:216–217, 1979

    Google Scholar 

  116. Abrahamova J, Majsky A, Koutecky J, Bek V: HLA system a germinalni nadory gonadalni a extragonadalni. Cas Lek Cesk 119:51–54, 1980

    PubMed  CAS  Google Scholar 

  117. Majsky A, Abrahamova J: Pritomnost HLA-A2 anti-genu na lymfocytech: Ochrana pred vznikem nadoru? Cas Lek Cesk 119:47–50, 1980

    PubMed  CAS  Google Scholar 

  118. Majsky A, Abrahamova J: Schützen die HLA-A2-Gene vor der Entwicklung eines Tumors? Eine Hypothese. Folia Haematol (Leipz) 108:90–96, 1981

    CAS  Google Scholar 

  119. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr, (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  120. DeWolf WC, Lange PH, Shepherd R, Martin-Alosco S, Yunis EJ: Association of HLA and renal cell carcinoma. Hum Immunol 1:41–44, 1981

    Google Scholar 

  121. Kuntz BME, Schmidt GD, Scholz S, Albeit ED: HLA-antigens and hypernephroma. Tissue Antigens 12:407–408, 1978

    PubMed  CAS  Google Scholar 

  122. Valleteau de Moulliac M, Ganansia R, Hors J, Letexier A, Morin M: Familial cancer of the kidney and the HLA sysyem (four cases of cancer of the left kidney in a sibship). Nouv Presse Med 3:1539–1542, 1974

    PubMed  CAS  Google Scholar 

  123. Braun WE, Strimlan CV, Negron AG, Straffon MRA, Zachary AA, Bartee SL, et al: The association of W17 with familial renal cell carcinoma. Tissue Antigens 6:101–104, 1975

    PubMed  CAS  Google Scholar 

  124. Pilepich MV, Berkman EM, Goodchild NT: HLA typing in familial renal carcinoma. Tissue Antigens 11:487–488, 1978

    PubMed  CAS  Google Scholar 

  125. Schacter B, Braun WE, Bukowski R, Deodhar S: HLA-B7 association with low spontaneous cell-mediated cytotoxicity (SP-CMC) to renal cell carcinoma cell lines. Transplant Proc 9:1849–1851, 1977

    PubMed  CAS  Google Scholar 

  126. Hors J, Dausset J: Maladies malignes identiques au sein d’une même famille. Nouv Presse Med 3:1237, 1974

    PubMed  CAS  Google Scholar 

  127. Jeannet M, Magnin C: HL-A antigens in malignant diseases. Transplant Proc 3:1301–1303, 1971

    Google Scholar 

  128. Lynch HT, Thomas RJ, Terasaki PI, Ting A, Guirgis HA, Kaplan AR, et al: HL-A in cancer family “N.” Cancer 36:1315–1320, 1975

    PubMed  CAS  Google Scholar 

  129. Gatti RA, Sparkes RD, Field LL, Spence MA, Harris NS, Freidin M: Genetic linkage analysis in a high-risk cancer family: HLA and 24 other markers. Cancer Genet Cytogenet 8:9–18, 1983

    PubMed  CAS  Google Scholar 

  130. Kersey JH, Yunis EJ, Todaro GJ, Aaronson SA: HL-A antigens of human tumor-derived cell lines and viral transformed fibroblasts in culture. Proc Soc Exp Biol Med 143:453–456, 1973

    PubMed  CAS  Google Scholar 

  131. Kourilsky FM: Symposium international sur les relations entre les antigenes de tumeurs et les systemes d’histocompatibilite. Bull Cancer 58:315–324, 1977

    Google Scholar 

  132. Dellon AL, Chretien PB, Potvin C, Rogentine GN JR: Multiple primary malignant neoplasms: A search for an immunogenetic basis. Arch Surg 110:156–160, 1975

    PubMed  CAS  Google Scholar 

  133. Pedersen-Bjergaard J, Philip P, Mortensen BT, Ersboll J, Jensen G, Panduro J, et al: Acute nonlym-phocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant disease. Blood 57:712–723, 1981

    PubMed  CAS  Google Scholar 

  134. Ferrone S, Pellegrino MA, Callahan GN: Human and murine tumours: Changes in cell surface structures coded by the major histocompatibility complex region. J Immunogenet 7:71–79, 1980

    PubMed  CAS  Google Scholar 

  135. Dickson A: A raised incidence of HL-A2 plus HL-A9 and other anomalies of the HL-A antigens of patients with leukemia. Acta Haematol 54:143–151, 1975

    PubMed  CAS  Google Scholar 

  136. Pegrum GD, Balfour IC, Evans CA, Middleton VL: HL-A antigens on leukemia cells. Br J Haematol 19:493–498, 1970

    PubMed  CAS  Google Scholar 

  137. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr, (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  138. Feingold N, Degos L, Feingold J: HLA in populations: An approach for genetical susceptibility to cancer. J Immunogenet 6:29–35, 1979

    PubMed  CAS  Google Scholar 

  139. Werner-Favre CH, Jeannet M: HLA compatibility in couples with children suffering from acute leukemia or aplastic anemia. Tissue Antigens 13:307–309, 1979

    PubMed  CAS  Google Scholar 

  140. Werner-Favre CH, Von Fliedner W, Jeannet M: Similitude des antigenes HLA chez les parents de patients atteints de leucemie aigue ou d’anémie aplastique. Schweiz Med Wochenschr 109:1399, 1979

    PubMed  CAS  Google Scholar 

  141. Tsuji K: Neoplasms, leukemia, and HLA antigens. Nippon Rinsho 36:3137–3142, 1978

    PubMed  CAS  Google Scholar 

  142. Editorial: Discussion on HLA by Drs. Laurber, Kourilsky, Walford, Thorsby, Sachs, and Morris. Transplant Proc 3:1311–1312, 1971

    Google Scholar 

  143. Billing RJ, Terasaki PI, Honig R, Peterson P: The absence of B-cell antigen B2 from leukaemia cells and lymphoblastoid cell lines. Lancet i: 1365–1367, 1976

    Google Scholar 

  144. Ellman L, Green I, Martin WJ: Histocompatibility genes, immmune responsiveness, and leukaemia. Lancet i: 1104–1106, 1970

    Google Scholar 

  145. Nedelkova M, Iliev D, Seratimov-Dimitrov W: Ueber die HL-A-Spezifitaet der Immunreaktion bei Parablastenleukosen. Folia Haematol 104:324–329, 1977

    CAS  Google Scholar 

  146. Kourilsky FM: Symposium international sur les relations entre les antigenes de tumeurs et les systemes d’histocompatibilite. Bull Cancer 58:315–324, 1977

    Google Scholar 

  147. Truia CI, Truia M, Iosub A, Mudric V, Costachel O: Variation of the HL-A antigens during neoplasm evolution. Physiologie 17:239–245, 1980

    PubMed  CAS  Google Scholar 

  148. Oliver RTD, Lee SK: Histocompatibility antigens and T cell responses to leukemia antigens. Haematol Bluttranfus 23:377–379, 1979

    CAS  Google Scholar 

  149. Newman RA, Delia D, Greaves MF, Navarrete C, Fainboim L, Festenstein H: Differential expression of HLA-DR-linked determinants on human leukemias and lymphoid cells. Eur J Immunol 13:172–176, 1983

    PubMed  CAS  Google Scholar 

  150. Morishima Y, Kawashima K, Yamada K, Minami S, Akaza T: Anomalous expression of histocompatibility antigens on human leukemia cells. Nippon Ketsueki Gakkai Zasshi 44:53–60, 1981

    PubMed  CAS  Google Scholar 

  151. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr, (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  152. Degos L, Drolet Y, Dausett J: HL-A antigens in chronic myeloid leukemia (CML) and chronic lymphoid leukemia (CLL). Transplant Proc 3:1309–1310, 1971

    Google Scholar 

  153. Mayer S, Tongio MM, Bigel P: Etude des antigens HL-A dans la leucemie myeloide chronique. Nouv Rev Fr Hematol 15:284–288, 1975

    PubMed  CAS  Google Scholar 

  154. Jeannet M, Magnin C: HL-A antigens in haemato-logical malignant diseases. Eur J Clin Invest 2:39–42, 1976

    Google Scholar 

  155. Jeannet M, Magnin C: HL-A antigens in malignant diseases. Transplant Proc 3:1301–1303, 1971

    Google Scholar 

  156. Pollack MS, Dubois D: Possible effects of non-HLA antibodies in common typing sera on HLA antigen frequency data in leukemia. Cancer 39:2348–2354, 1977

    PubMed  CAS  Google Scholar 

  157. Miller WV: HL-A antigens and hematologic malignancy. Arch Intern Med 133:397–399, 1974

    PubMed  CAS  Google Scholar 

  158. Hester JP, Rossen R, Trujillo J, McCredie KB, Freireich EJ: Frequency of HLA antigens in chronic myelocytic leukemia. South Med J 70:691–693, 1977

    PubMed  CAS  Google Scholar 

  159. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr, (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  160. Tananov AT, Kutyina RM, Turbina NS, Abakumov EM, Polyanskaya AM, Isaev VG, et ai: HLA antigens in patients with blood pathology. Probl Gematol Pereliv Krovi 26:8–12, 1981

    PubMed  CAS  Google Scholar 

  161. Morozova LF, Belyanchikova NI, Radzikhovskaya RM, Baryshnikov AYU, Volkova MA, Vinogra-dova MA et al: Discovery of B cell antigen on blast cells of patients with chronic myeloid leukemia. Biull Eksp Biol Med 87:574–576, 1979

    PubMed  CAS  Google Scholar 

  162. Fingold N: Critical analysis of relationships between HL-A system and susceptibility to disease. Transplant Proc 3:1317–1320, 1971

    Google Scholar 

  163. Walford RL, Smith GS, Waters H: Histocompatibility systems and disease states with particular reference to cancer. Transplant Rev 7:78–111, 1971

    PubMed  CAS  Google Scholar 

  164. Dickson A: A raised incidence of HL-A2 plus HL-A9 and other anomalies of the HL-A antigens of patients with leukemia. Acta Haematol 54:143–151, 1975

    PubMed  CAS  Google Scholar 

  165. Billing RJ, Terasaki PI, Honig R, Peterson P: The absence of B-cell antigen B2 from leukaemia cells and lymphoblastoid cell lines. Lancet i: 1365–1367, 1976

    Google Scholar 

  166. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr, (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  167. Pollack MS, Dubois D: Possible effects of non-HLA antibodies in common typing sera on HLA antigen frequency data in leukemia. Cancer 39:2348–2354, 1977

    PubMed  CAS  Google Scholar 

  168. Heise E, Parrish E, Cooper R: HLA-B17 and the HL A-Al, B17 haplotype in acute myelogenous leukemia. Tissue Antigens 14:98–104, 1979

    PubMed  CAS  Google Scholar 

  169. Albert ED, Nisperos B, Thomas ED: HLA antigens and haplotypes in acute leukemia. Leukemia Res 1:261–269, 1977

    Google Scholar 

  170. Richter KV, Fischer G, Menzel GR, Langfeld M, Aigte H, Ruckwarth G, et al: HL-A antigene und Disposition fur hamatologische Maligne Erkrankungen. Haematologia 7:203–209, 1973

    PubMed  CAS  Google Scholar 

  171. Harris R, Zuhrie SR, Taylor GM, Freeman CB, Wentzel J, Geary C, et al: Influence of HLA, ABO, and RH(D) on survival after remission in acute myelogenous leukaemia. Lancet ii:653, 1977

    Google Scholar 

  172. Oliver RTD, Pillai A, Klouda PT, Lawler SD: HLA linked resistance factors and survival in acute myelogenous leukemia. Cancer 39:2337–2341, 1977

    PubMed  CAS  Google Scholar 

  173. Jeannet M, Magnin C: HL-A antigens in haemato-logical malignant diseases. Eur J Clin Invest 2:39–42, 1976

    Google Scholar 

  174. Jeannet M, Magnin C: HL-A antigens in malignant diseases. Transplant Proc 3:1301–1303, 1971

    Google Scholar 

  175. Von Fliedner VE, Khan ZS, Jeannet M: HLA-A and HLA-B antigens in acute leukemia: A2-B12 phenotypes correlate with longer survival in acute myelogenous leukemia. Acta Haematol 65:73–78, 1981

    Google Scholar 

  176. Tananov AT, Kutyina RM, Turbina NS, Abakumov EM, Polyanskaya AM, Isaev VG, et al: HLA antigens in patients with blood pathology. Prob Gematol Pereliv Krovi 26:8–12, 1981

    CAS  Google Scholar 

  177. De Mouzon A, Tongio MM, Jeannet M, Betuel H, De Boissezon JF, De Moerloose PH, et al: IA like serology in leukemia. Tissue Antigens 10:211, 1977

    Google Scholar 

  178. Von Fliedner V, Sultan-Khan Z, Jeannet M: HLA DRW antigens associated with acute leukemia. Blut 41:244–245, 1980

    Google Scholar 

  179. Von Fliedner VE, Sultan-Khan Z, Jeannet M: HLA-DRW antigens associated with acute leukemia. Tissue Antigens 16:399–404, 1980

    Google Scholar 

  180. Warren RP, Strob R, Nguyen DD, Thomas ED: Association between leucocyte group-5A antigen and acute lymphoblastic leukaemia. Lancet i:509–510, 1977

    Google Scholar 

  181. Warren RP, Storb R, Nelson NJ, Sale GE, Thomas ED: Increased frequency of the group 5a antigen in patients with hematologic malignancies. Tissue Antigens 18:85–91, 1981

    PubMed  CAS  Google Scholar 

  182. Chan KW, Pollack MS, Braun D, O’Reilly RJ, Dupont B: Distribution of HLA genotypes in families of patients with acute leukemia. Implications for transplantation. Transplantation 33:613–615, 1982

    PubMed  CAS  Google Scholar 

  183. Harris R, Lawler SD, Oliver RTD: The HLA system in acute leukaemia and Hodgkin’s disease. Br Med Bull 34:301–304, 1978

    PubMed  CAS  Google Scholar 

  184. Pendergrass TW, Stoller RG, Mann DL, Halterman RH, Fraumeni JF: Acute myelocytic leukaemia and leukaemia-associated antigens in sisters. Lancet ii:429–431, 1975

    Google Scholar 

  185. Zebrowski A, Billing R, Mikulski SM, Gale RP, Terasaki PI: Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells: Lymphocyte-dependent antibody studies with rabbit antisera. Leukemia Res 1:13–18, 1977

    Google Scholar 

  186. Fingold N: Critical analysis of relationships between HL-A system and susceptibility to disease. Transplant Proc 3:1317–1320, 1971

    Google Scholar 

  187. Zier KS, Huber C, Albert E, Braunsteiner H: Cellmediated immune responses between HLA-identical siblings: Recognition of antigenic changes associated with acute myelogenous leukaemia. Clin Exp Immunol 40:136–146, 1980

    PubMed  CAS  Google Scholar 

  188. Dickson A: A raised incidence of HL-A2 plus HL-A9 and other anomalies of the HL-A antigens of patients with leukemia. Acta Haematol 54:143–151, 1975

    PubMed  CAS  Google Scholar 

  189. Billing RJ, Terasaki PI, Honig R, Peterson P: The absence of B-cell antigen B2 from leukaemia cells and lymphoblastoid cell lines. Lancet i: 1365–1367, 1976

    Google Scholar 

  190. Mayer S, Tongio MM, Falkenrodt A, Pfeiffer B, Bergerat JP: Expression of HLA antigens on leukaemia cells. J Immunogenet 9:111–120, 1982

    PubMed  CAS  Google Scholar 

  191. Morísima Y, Yamada K, Minami S, Kawashima K, Akaza T: HLA-A, B antigens in acute leukemia. Nippon Ketsueki Gakkae Zasshi 48:805–808, 1980

    Google Scholar 

  192. Kourilsky FM, Dausset J, Feingold N, Duput JM, Bernard J: Etude de la repartition des antigenes leucocytaires chez des malades atteints de leucemie aigue en remission. In J Dausset, J Hamburger, G Mathe (eds): Advances in Transplantation. Munksgaard, Copenhagen, 1967, pp 515–522

    Google Scholar 

  193. Walford RL, Finkelstein S, Neerhout R, Konrad P, Shanbrom E: Acute childhood leukaemia in relation to the HL-A human transplantation genes. Nature 225:461–462, 1970

    PubMed  CAS  Google Scholar 

  194. Lawler SD, Klouda PT, Hardisty RM, Till MM: Histocompatibility and acute lymphoblastic leukaemia. Lancet i:699, 1971

    Google Scholar 

  195. Batchelor JR, Edwards JH, Stuart J: Histocompatibility and acute lymphoblastic leukaemia. Lancet i:699, 1971

    Google Scholar 

  196. Albert ED, Nisperos B, Thomas ED: HLA antigens and haplotypes in acute leukemia. Leukemia Res 1:261–269, 1977

    Google Scholar 

  197. Rogentine GN, Trapani RJ, Yankee RA, Henderson ES: HL-A antigens and acute lymphocytic leukemia: The nature of the HL-A2 association. Tissue Antigens 3:470–476, 1973

    PubMed  CAS  Google Scholar 

  198. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  199. Sanderson AR, Mahour GH, Jaffe N, Das L: Incidence of HL-A antigens in acute lymphocytic leukemia. Tranplantation 16: 672–673, 1973

    CAS  Google Scholar 

  200. Walford RL, Zeller E, Combs L, Konrad P: HL-A specificities in acute and chronic leukemia. Transplant Proc 3:1297–1300, 1971

    Google Scholar 

  201. De Moerloose PH, Chardonnens X, Vassalli P, Jeannet M: Antigenes HLA-D des lymphocytes B et susceptibilité a certaines maladies. Schweiz Med Wochenschr 107:1461, 1977

    PubMed  Google Scholar 

  202. Von Riedner V, Sultan-Khan Z, Jeannet M: HLA DRW antigens associated with acute leukemia. Blut 41:244–245, 1980

    Google Scholar 

  203. Von Fliedner VE, Sultan-Khan Z, Jeannet M: HLA-DRW antigens associated with acute leukemia. Tissue Anigens 16:399–404, 1980

    Google Scholar 

  204. Michel K, Hubbel C, Dock NL, Davey FR: Correlation of HLA-DRw3 with childhood acute lymphocytic leukemia. Arch Pathol Lab Med 105:560, 1981

    PubMed  CAS  Google Scholar 

  205. De Jongh BM, Van Der Does-Van Den Berg A, Schreuder GM: Random HLA-DR distribution in children with acute lymphocytic leukaemia in long-term continuous remission. Br J Haematol 52:161–169, 1982

    PubMed  Google Scholar 

  206. Casper JT, Marran M, Piaskowski V, Lauer S J, Dequesnoy RJ: Association between HLA-D region antigens and disease-free survival in childhood non-T, non-B acute lymphocytic leukemia. Blood 60:698–702, 1982

    PubMed  CAS  Google Scholar 

  207. Warren RP, Strob R, Nguyen DD, Thomas ED: Association between leucocyte group-5A antigen and acute lymphoblastic leukaemia. Lancet i:509–510, 1977

    Google Scholar 

  208. Warren RP, Storb R, Nelson NJ, Sale GE, Thomas ED: Increased frequency of the group 5a antigen in patients with hematologic malignancies. Tissue Antigens 18:85–91, 1981

    PubMed  CAS  Google Scholar 

  209. Lawler SD, Klouda PT, Smith PG, Till MM, Hardisty RM: Survival and the HL-A system in acute lymphoblastic leukemia. Br Med J 1:547–548, 1974

    PubMed  CAS  Google Scholar 

  210. Klouda PT, Lawler SD, Till MM, Hardisty RM: Acute lymphoblastic leukemia and HL-A: A prospective study. Tissue Antigens 4:262–265, 1974

    PubMed  CAS  Google Scholar 

  211. De Bruyere M, Cornu G, Heremans-Bracke T, Malchaire J, Sokal G: HLA haplotypes and long survival in childhood acute lymphoblastic leukaemia treated with transfer factor. Br J Haematol 44:243–251, 1980

    PubMed  Google Scholar 

  212. Von Fliedner VE, Khan ZS, Jeannet M: HLA-A and HLA-B antigens in acute leukemia: A2-B12 phenotypes correlate with longer survival in acute myelogenous leukemia. Acta Haematol 65:73–78, 1981

    Google Scholar 

  213. Davey FR, Lachant NA, Dock NL, Hubbel C, Stockman JA, Henry JB: HLA antigens and childhood acute lymphocytic leukaemia. Br J Haematol 47:211–220, 1981

    PubMed  CAS  Google Scholar 

  214. De Bruyere M, Cornu G, Ninane J, Latinne D, Lebacq AM, Sokal G: HLA-DR antigens in childhood acute lymphoblastic leukaemia long survival. Br J Haematol 51:659–665, 1982

    PubMed  Google Scholar 

  215. Tursz T, Hors J, Lipinski M, Amiel JL: Phenotypes HLA des malades survivants a long terme apres immunotherapie par le BCG dans la leucemie aigue lymphoblastique de l’enfant. C R Acad Sci Paris 285:1585–1586, 1977

    CAS  Google Scholar 

  216. Tursz T, Hors J, Lipinski M, Aamiel JL: HLA phenotypes in long-term survivors treated with BCG immunotherapy for childhood all. Br Med J 1:1250–1251, 1978

    PubMed  CAS  Google Scholar 

  217. Hors J, Dausset J: Maladies malignes identiques au sein d’une même famille. Nouv Presse Med 3:1237, 1974

    PubMed  CAS  Google Scholar 

  218. Chan KW, Pollack MS, Braun D, O’Reilly RJ, Dupont B: Distribution of HLA genotypes in families of patients with acute leukemia. Implications for transplantation. Transplantation 33:613–615, 1982

    PubMed  CAS  Google Scholar 

  219. MacSween JM, Fernandez LA, Eastwood SL, Pyesmany AF: Restricted genetic heterogeneity in families of patients with acute lymphocytic leukemia. Tissue Antigens 16:70–72, 1980

    PubMed  CAS  Google Scholar 

  220. Fu SM, Winchester RJ, Kunkel HG: The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias. J Exp Med 142:1334–1338, 1975

    PubMed  CAS  Google Scholar 

  221. Zebrowski A, Billing R, Mikulski SM, Gale RP, Terasaki PI: Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells: Lymphocyte-dependent antibody studies with rabbit antisera. Leukemia Res 1:13–18, 1977

    Google Scholar 

  222. Morozova LF, Belyanchikova NI, Radzikhovskaya RM, Baryshnikov AYU, Volkova MA, Vinogrdova MA, et al: Discovery of B cell antigen on blast cells of patients with chronic myeloid leukemia. Biull Eksp Biol Med 87:574–576, 1979

    PubMed  CAS  Google Scholar 

  223. Jeannet M, Magnin C: HL-A antigens in malignant diseases. Transplant Proc 3:1301–1303, 1971

    Google Scholar 

  224. Fingold N: Critical analysis of relationships between HL-A system and susceptibility to disease. Transplant Proc 3:1317–1320, 1971

    Google Scholar 

  225. Thorsby E, Engeset A, Lie SO: HL-A antigens and susceptibility to disease. Tissue Antigens 1:147–152, 1971

    PubMed  CAS  Google Scholar 

  226. Pegrum GD, Balfour IC, Evans CA, Middleton VL: HL-A typing of “leukaemic” cells. Lancet i:852–853, 1971

    Google Scholar 

  227. Walford RL, Smith GS, Waters H: Histocompatibility systems and disease states with particular reference to cancer. Transplant Rev 7:78–111, 1971

    PubMed  CAS  Google Scholar 

  228. Lawler SD, Klouda PT, Hardisty RM, Till MM: The HL-A system in lymphoblastic leukaemia. Br J Haematol 21:595–605, 1971

    PubMed  CAS  Google Scholar 

  229. Urcan S, Cote GB, Edwards JH: HL-A and susceptibility to acute lymphoblastic leukaemia. Ann Genet 17:73–76, 1974

    PubMed  CAS  Google Scholar 

  230. Rogentine GN Jr, Yankee RA, Gart JJ, Nam J, Trapani RJ: HL-A antigens and disease: Acute lymphocytic leukemia. J Clin Invest 51:2420–2428, 1972

    PubMed  Google Scholar 

  231. Davey FR, Henry JB, Gottlieb AJ: HL-A antigens in lymphatic leukaemia. Lancet ii:802, 1973

    Google Scholar 

  232. Bradstock KF, Janossy G, Bollum FJ, Milstein C: Anomalous phenotype in thymic acute lymphoblastic leukaemia. Nature 284:455–457, 1980

    PubMed  CAS  Google Scholar 

  233. Dickson A: A raised incidence of HL-A2 plus HL-A9 and other anomalies of the HL-A antigens of patients with leukemia. Acta Haematol 54:143–151, 1975

    PubMed  CAS  Google Scholar 

  234. Pollack MS, Dubois D: Possible effects of non-HLA antibodies in common typing sera on HLA antigen frequency data in leukemia. Cancer 39:2348–2354, 1977

    PubMed  CAS  Google Scholar 

  235. Morisima Y, Yamada K, Minami S, Kawashima K, Akaza T: HLA-A, B antigens in acute leukemia. Nippon Ketsueki Gakkae Zarshi 48:805–808, 1980

    Google Scholar 

  236. Davey FR, Henry JB, Gottlieb AJ: HL-A antigens and acute lymphocytic leukemia. Am J Clin Pathol 61:662–665, 1974

    PubMed  CAS  Google Scholar 

  237. Dick FR, Fortuny I, Theologides A, Greally J, Wood N, Yunis E: HL-A and lymphoid tumors. Cancer Res 32:2608–2611, 1972

    PubMed  CAS  Google Scholar 

  238. Tananov AT, Kutyina RM, Turbina NS, Abakumov EM, Polyanskaya AM, Isaev VG, et al: HLA antigens in patients with blood pathology. Prob Gematol Pereliv Krovi 26:8–12, 1981

    CAS  Google Scholar 

  239. Jeannet M, Magnin C: HL-A antigens in haemato-logical malignant diseases. Eur J Clin Invest 2:39–42, 1976

    Google Scholar 

  240. Thorsby E, Lie SO: Relationship between the HL-A system and susceptibility to disease. Tranplant Proc 3:1305–1307, 1971

    Google Scholar 

  241. Billing RJ, Terasaki PI, Honig R, Peterson P: The absence of B-cell antigen B2 from leukaemia cells and lymphoblastoid cell lines. Lancet i: 1365–1367, 1976

    Google Scholar 

  242. Kourilsky FM, Dausset J, Feingold N, Dupey JM, Bernard J: Leukocyte groups and acute leukemia. J Natl Cancer Inst 41:81–87, 1968

    PubMed  CAS  Google Scholar 

  243. Casper JT, Duquesnoy RJ, Borella L: Transient appearance of HLA-DRW-positive leukocytes in peripheral blood after cessation of antileukemia therapy. Transplant Proc 12:130–133, 1980

    PubMed  CAS  Google Scholar 

  244. Hattori T, Uchiyama T, Takatsuki K, Uchino H: Presence of human B-lymphocyte antigens on adult T-cell leukemia cells. Clin Immunol Immunopathol 17:287–295, 1980

    PubMed  CAS  Google Scholar 

  245. Hors J: HLA and susceptibility to malignancies in humans. Bull Cancer (Paris) 69:199–207, 1982

    CAS  Google Scholar 

  246. Jeannet M, Magnin C: HL-A antigens in haemato-logical malignant diseases. Eur J Clin Invest 2:39–42, 1976

    Google Scholar 

  247. Jeannet M, Magnin C: HL-A antigens in malignant diseases. Transplant Proc 3:1301–1303, 1971

    Google Scholar 

  248. Jeannet M, Alberto P: HL-A antigens in chronic lymphocytic leukemia: Preliminary evidence for the existence of (leukemia specific) antigens. Schweiz Med Wochenschr 102:1170–1172, 1972

    PubMed  CAS  Google Scholar 

  249. Walford RL, Zeller E, Combs L, Konrad P: HL-A specificities in acute and chronic leukemia. Transplant Proc 3:1297–1300, 1971

    Google Scholar 

  250. Miller WV: HL-A antigens and hematologic malignancy. Arch Intern Med 133:397–399, 1974

    PubMed  CAS  Google Scholar 

  251. Pollack MS, Dubois D: Possible effects of non-HLA antibodies in common typing sera on HLA antigen frequency data in leukemia. Cancer 39:2348–2354, 1977

    PubMed  CAS  Google Scholar 

  252. Dick FR, Fortuny I, Theologides A, Greally J, Wood N, Yunis E: HL-A and lymphoid tumors. Cancer Res 32:2608–2611, 1972

    PubMed  CAS  Google Scholar 

  253. Fingold N: Critical analysis of relationships between HL-A system and susceptibility to disease. Transplant Proc 3:1317–1320, 1971

    Google Scholar 

  254. Zotikov EA, Tananov AG, Musatova VS: Leucocy-tic antigens in man (HL-A) and diseases of the blood. Sov Med 7:25–28, 1976

    Google Scholar 

  255. Tananov AT, Kutyina RM, Turbina NS, Abakumov EM, Polyanskaya AM, Isaev VG, et al: HLA antigens in patients with blood pathology. Prob Gematol Pereliv Krovi 26:8–12, 1981

    CAS  Google Scholar 

  256. Richter KV, Fischer G, Menzel GR, Langfeld M, Aigte H, Ruckwarth G, et al: HL-A Antigene und Disposition fur hamatologische Maligne Erkrankungen. Haematologia 7:203–209, 1973

    PubMed  CAS  Google Scholar 

  257. De Mouzon A, Tongio MM, Jeannet M, Betuel H, De Boissezon JF, De Moerloose PH, et al: IA like serology in leukemia. Tissue Antigens 10:211, 1977

    Google Scholar 

  258. Winchester R, Toguchi T, Szer I, Burmester G, Lo Galbo P, Cuttner J, et al: Association of susceptibility to certain hematopoietic malignancies with the presence of la allodeterminants distinct from the DR series. Immunol Rev 70:155–165, 1983

    PubMed  CAS  Google Scholar 

  259. Hors J, Dausset J: Maladies malignes identiques au sein d’une même famille. Nouv Presse Med 3:1237, 1974

    PubMed  CAS  Google Scholar 

  260. Dickson A: A raised incidence of HL-A2 plus HL-A9 and other anomalies of the HL-A antigens of patients with leukemia. Acta Haematol 54:143–151, 1975

    PubMed  CAS  Google Scholar 

  261. Degos L, Drolet Y, Dausett J: HL-A antigens in chronic myeloid leukemia (CML) and chronic lymphoid leukemia (CLL). Transplant Proc 3:1309–1310, 1971

    Google Scholar 

  262. Billing RJ, Terasaki PI, Honig R, Peterson P: The absence of B-cell antigen B2 from leukaemia cells and lymphoblastoid cell lines. Lancet i: 1365–1367, 1976

    Google Scholar 

  263. Walford RL, Smith GS, Waters H: Histocompatibility systems and disease states with particular reference to cancer. Transplant Rev 7:78–111, 1971

    PubMed  CAS  Google Scholar 

  264. Warren RP, Storb R, Nelson NJ, Sale GE, Thomas ED: Increased frequency of the group 5a antigen in patients with hematologic malignancies. Tissue Antigens 18:85–91, 1981

    PubMed  CAS  Google Scholar 

  265. Winchester R, Toguchi T, Szer I, Burmester G, Lo Galbo P, Cuttner J, et al: Association of susceptibility to certain hematopoietic malignancies with the presence of la allodeterminants distinct from the DR series. Immunol Rev 70:155–165, 1983

    PubMed  CAS  Google Scholar 

  266. Naeim F, Gatti RA, Gossett T, Johns S, Walford RL: HLA and “B-cell” alloantigens in “hairy” cell leukemia. Tissue Antigens 10:210, 1977

    Google Scholar 

  267. Wylin RF, Greene MH, Palutke M, Khilanani P, Tabaczka P, Swiderski G: Hairy cell leukemia in three siblings: An apparent HLA-linked disease. Cancer 49:538–542, 1982

    PubMed  CAS  Google Scholar 

  268. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  269. Terasaki PI, Perdue ST, and Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  270. Jeannet M, Magnin C: HL-A antigens in haemato-logical malignant diseases. Eur J Clin Invest 2:39–42, 1976

    Google Scholar 

  271. Jeannet M, Magnin C: HL-A antigens in malignant diseases. Transplant Proc 3:1301–1303, 1971

    Google Scholar 

  272. Dick FR, Fortuny I, Theologides A, Greally J, Wood N, Yunis E: HL-A and lymphoid tumors. Cancer Res 32:2608–2611, 1972

    PubMed  CAS  Google Scholar 

  273. Seigier HF, Kremer WB, Metzgar RS, Ward FE, Haung AT, Arnos DB: HL-A antigenic loss in malignant tranformation. J Natl Cancer Inst 46:577–584, 1971

    Google Scholar 

  274. Editorial: Genes may indicate prognosis in lymphoma. JAMA 235:2808, 1976

    Google Scholar 

  275. Walford RL, Smith GS, Waters H: Histocompatibility systems and disease states with particular reference to cancer. Transplant Rev 7:78–111, 1971

    PubMed  CAS  Google Scholar 

  276. Naeim F, Stoddard A, Smith GS, Walford RL: HL-A antigens on cells isolated from malignant and nonmalignant lymph nodes. Tissue Antigens 4:166–171, 1974

    PubMed  CAS  Google Scholar 

  277. Kadin ME: Ia-like (HLA-DR) antigens in the diagnosis of lymphoma and undifferentiated tumors. Arch Pathol Lab Med 104:503–508, 1980

    PubMed  CAS  Google Scholar 

  278. Forbes JF, Morris PJ: Transplantation antigens and malignant lymphomas in man: Follicular lymphoma, reticulum cell sarcoma and lymphosarcoma. Tissue Antigens 1:265–269, 1971

    PubMed  CAS  Google Scholar 

  279. Morris PJ, Forbes JF: HL-A in follicular lymphoma, reticulum cell sarcoma, lymphosarcoma, and infectious mononucleosis. Transplant Proc 3:1315–1316, 1971

    Google Scholar 

  280. Dausset J, Singh S, Gourand JL, Degos L, Solal CH, Klein G: HL-A and Burkitt’s disease. Tissue Antigens 5:48–51, 1975

    PubMed  CAS  Google Scholar 

  281. Dick HM, Steel CM, Levin AG, Henderson N: Burkitt’s lymphoma and HL-A antigens. Tissue Antigens 5:52–58, 1975

    PubMed  CAS  Google Scholar 

  282. Bodmer JG, Bodmer WF, Ziegler J, Magrath IT: HL-A and Burkitt’s tumour—A study in Uganda. Tissue Antigens 5:59–62, 1975

    PubMed  CAS  Google Scholar 

  283. Bodmer JG, Bodmer WF, Pickbourne P, Degos L, Dausset J, Dick HM: Combined analysis of three studies of patients with Burkitt’s lymphoma. Tissue Antigens 5:63–68, 1975

    PubMed  CAS  Google Scholar 

  284. Jones EH, Biggar RJ, Nkrumah FK, Lawler SD: Study of the HLA system in Burkitt’s lymphoma. Hum Immunol 3:207–210, 1980

    Google Scholar 

  285. Joncas JH, Rioux E, Wastiaux JP, Leyritz M, Robillard L, Menezes J: Nasopharyngeal carcinoma and Burkitt’s lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins. Can Med Assoc J 115:858–860, 1976

    PubMed  CAS  Google Scholar 

  286. Kalil J, Fellous M, Tanigaki N, Rosa F, Pagniez C, Herzog C, et al: A new Epstein-Barr virus negative Burkitt’s lymphoma derived cell-line. Tissue Antigens 20:47–62, 1982

    PubMed  CAS  Google Scholar 

  287. Hors J, Dausset J: Maladies malignes identiques au sein d’une même famille. Nouv Presse Med 3:1237, 1974

    PubMed  CAS  Google Scholar 

  288. Majsky A, Abrahamova J, Koutecky J: HLA antigens and neuroblastoma. Tissue Antigens 12:156, 1978

    PubMed  CAS  Google Scholar 

  289. Abrahamova J, Majsky A, Koutecky J: HLA system U wilmsova nadoru a neuroblastomu. Cesk Pediatr 4:268–270, 1979

    Google Scholar 

  290. Abrahamova J, Majsky A, Koutecky J: Neuroblastoma and the HLA system. Cas Lek Cesk 117:593–594, 1978

    PubMed  CAS  Google Scholar 

  291. McAlack RF: Normal HLA phenotypes and neo-HLA-like antigens on cultured human neuroblastoma. Transplant Proc 12:107–113, 1980

    PubMed  CAS  Google Scholar 

  292. Majsky A, Abrahamova J: Pntomnost HLA-A2 antigenu na lymfocytech: Ochrana pred vznikem nadoru? Cas Lek Cesk 119:47–50, 1980

    PubMed  CAS  Google Scholar 

  293. Majsky A, Abrahamova J: Schutzen die HLA-A2-Gene vor der Entwicklung eines Tumors? Eine Hypothese. Folia Haematol (Leipz) 108:90–96, 1981

    CAS  Google Scholar 

  294. Bertrams J, Schildberg P, Hopping W, Böhme U, Albeit E: HL-A antigens in retinoblastoma. Tissue Antigens 3:78–87, 1973

    PubMed  CAS  Google Scholar 

  295. Schildberg P, Bertrams J, Hopping W, Kuweit E: Histokompatibilitats (HL-A)-Antigene beim Retinob-lastom. Albrecht Von Graefes Arch Klin Ophthalmol 186:33–38, 1973

    CAS  Google Scholar 

  296. Jones JL: Immunogenetics of retinoblastoma. Trans Ophthalmol Soc UK 94:945–952, 1974

    PubMed  CAS  Google Scholar 

  297. Ignatov RK, Terenteva LS, Shulgina NS: A study of antigen distribution of HLA-system in melanoblastoma of the uvea. Oftalmol Zh 32:289–294, 1977

    PubMed  CAS  Google Scholar 

  298. Dieckhues B, Junemann G, Kuchle HJ, Puttman T: HLA-Antigene bei Augenerkrankungen. Klin Monatsbl Augenheilkd 175:681–685, 1979

    PubMed  CAS  Google Scholar 

  299. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  300. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr(eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  301. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  302. Clark DA, Necheles T, Nathanson L, Silverman E: Apparent HL-A5 deficiency in malignant melanoma. Transplantation 15:326–328, 1973

    PubMed  CAS  Google Scholar 

  303. Clark DA, Necheles TF, Nathanson L, Whitten D, Silverman E, Flowers A: Apparent HL-A5 deficiency in human malignant melanoma: The HLA-A5 masking activity in sera of patients with progressing disease. Isr J Med Sci 10:836–846, 1974

    Google Scholar 

  304. Pandey JP, Johnson AH, Fudenberg HH, Amos DB, Gutterman JU, Hersh EM: HLA antigens and immunoglobulin allotypes in patients with malignant melanoma. Hum Immunol 2:185–190, 1981

    PubMed  CAS  Google Scholar 

  305. Singal DP, Bent PB, McCulloch PB, Blajchman MA, MacLaren RGC: HL-A antigens in malignant melanoma. Transplantation 18:186, 1974

    PubMed  CAS  Google Scholar 

  306. VanWijck R, Bouillenne C: HL-A antigen and susceptibility to malignant melanoma. Transplant 16:371, 1973

    CAS  Google Scholar 

  307. Cordon AL: HL-A and malignant melanoma. Lancet i:938, 1973

    Google Scholar 

  308. Bergholtz B, Brennhovd I, Klepp O, Kaakinen A, Thorsby E: HLA antigens in malignant melanoma. Cancer 39:2342–2344, 1977

    PubMed  CAS  Google Scholar 

  309. Bigel P, Heid E, Tongio MM, Mayer S: Melanomes malins et antigenes HL-A. Ann Dermatol Syphiligr (Paris) 102:63–65, 1975

    CAS  Google Scholar 

  310. Lamm LU, Kissmeyer-Nielsen F, Kjerbye KE, Mogensen B, Petersen NC: HL-A and ABO antigens and malignant melanoma. Cancer 33:1458–1461, 1974

    PubMed  CAS  Google Scholar 

  311. Pellegris G, Illeni MT, Vaglini M, Rovini D, Cascinelli N, Masserini C: HLA antigens in maligant melanoma patients. Tumori 66:51–58, 1980

    PubMed  CAS  Google Scholar 

  312. Nathanson SD, Park MS, Drew I, Morton DL, Terasaki PI: Serologically defined B-lymphocyte antigen expression in patients with malignant melanoma. Surg Forum 30:147–149, 1979

    PubMed  CAS  Google Scholar 

  313. Nathanson SD, Park MS, Drew SI, Morton DL, Terasaki PI: First and second B-lymphocyte antigen expression in malignant melanoma. Transplant Proc 12:118–120, 1980

    PubMed  CAS  Google Scholar 

  314. Barger BO, Acton RT, Soong SJ, Roseman J, Balch C: Increase of HLA-DR4 in melanoma patients from Alabama. Cancer Res 42:4276–4279, 1982

    PubMed  CAS  Google Scholar 

  315. Hawkins BR, Dawkins RL, Hockey A, Houliston JB, Kirk RL: Evidence for linkage between HLA and malignant melanoma. Tissue Antigens 17:540–541, 1981

    PubMed  CAS  Google Scholar 

  316. Ruiter DJ, Bhan AK, Harrist TJ, Sober AJ, Mihm Jr MC: Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevo-melanocytic proliferations and malignant melanoma. J Immunol 129:2808–2815, 1982

    PubMed  CAS  Google Scholar 

  317. Mitchell KF, Ward FE, Koprowski H: DR antigens on melanoma cells: Analysis with monoclonal antibodies. Hum Immunol 4:15–26, 1982

    PubMed  CAS  Google Scholar 

  318. Nathanson SD, Pellegrino MA, Ferrone S: Serum HLA-A and B alloantigens in patients with malignant melanoma. Transplant Proc 13:1939–1941, 1981

    PubMed  CAS  Google Scholar 

  319. Hors J: HLA and susceptibility to malignancies in humans. Bull Cancer (Paris) 69:199–207, 1982

    CAS  Google Scholar 

  320. Pollack MS, Livingston PO, Fogh J, Carey TE, Oettgen HF, Dupont B: Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines. Tissue Antigens 15:249–256, 1980

    PubMed  CAS  Google Scholar 

  321. Liao SK, Kwong PC, Dent PB, Jerry LM: Changes in HLA-DR antigen expression on cultured human melanoma cells during theophylline treatment. Tissue Antigens 20:147–151, 1982

    PubMed  CAS  Google Scholar 

  322. Pellegrino MA, Ferrone S, Reisfeld RA, Irie RF, Golub SH: Expression of histocompatibiliy (HLA) antigens on tumour cells and normal cells from patients with melanoma. Cancer 40:36–41, 1977

    PubMed  CAS  Google Scholar 

  323. Bertrams J, Spitznas M, Rommelfanger M: Missing evidence for HLA antigen association with Eales’ disease, chorioretinitis, central serous retinopathy, and malignant choroidal melanoma. Invest Ophthalmol Vis Sci 17:918–920, 1978

    PubMed  CAS  Google Scholar 

  324. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  325. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr, (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  326. Forbes JF, Morris PJ: Transplantation antigens and malignant lymphomas in man: Follicular lymphoma, reticulum cell sarcoma and lymphosarcoma. Tissue Antigens 1:265–269, 1971

    PubMed  CAS  Google Scholar 

  327. Morris PJ, Forbes JF: HL-A in follicular lymphoma, reticulum cell sarcoma, lymphosarcoma, and infectious mononucleosis. Transplant Proc 3:1315–1316, 1971

    Google Scholar 

  328. Miller WV: HL-A antigens and hematologic malignancy. Arch Intern Med 133:397–399, 1974

    PubMed  CAS  Google Scholar 

  329. Forbes JF, Morris PJ: Transplantation antigens and malignant lymphomas in man: Follicular lymphoma, reticulum cell sarcoma and lymphosarcoma. Tissue Antigens 1:265–269, 1971

    PubMed  CAS  Google Scholar 

  330. Morris PJ, Forbes JF: HL-A in follicular lymphoma, reticulum cell sarcoma, lymphosarcoma, and infectious mononucleosis. Transplant Proc 3:1315–1316, 1971

    Google Scholar 

  331. Fieldsteel AH, Dawson PJ, Kurahara C: Tumor-specific transplantation antigens in reticulum cell sarcomas and lymphomas induced by the Friend virus complex. Cancer Res 33:551–558, 1973

    PubMed  CAS  Google Scholar 

  332. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  333. Chan KW, Rosen G, Pollack MS: Distribution of HLA antigens in patients with Ewing’s sarcoma. Tissue Antigens 16:314–316, 1980

    PubMed  CAS  Google Scholar 

  334. Tarpley JL, Chretien PB, Rogentine N, Twomey PL, Dellon AL: Histocompatibility antigens and solid malignant neoplasms. Arch Surg 110:269–271, 1975

    PubMed  CAS  Google Scholar 

  335. Tabacchi P, Chiricolo M, Cenci M, Barboni F, Mannfrini M, Bacci G, et al: Frequency and prognostic value of HLA antigens in osteosarcoma patients. Tissue Antigens 20:251–253, 1982

    PubMed  CAS  Google Scholar 

  336. Brenner S, Krakowski A, Schewach-Millet M, Ronen M, Orgad S, Gazit E: Increased frequency of HLA-Awl9 in Kaposi’s sarcoma. Tissue Antigens 19:392–394, 1982

    PubMed  CAS  Google Scholar 

  337. Pollack MS, Safai B, Myskowski PL, Gold JWM, Pandey J, Dupont B: Frequencies of HLA and Gm immunogenetic markers in Kaposi’s sarcoma. Tissue Antigens 21:1–8, 1983

    PubMed  CAS  Google Scholar 

  338. Lawler SD, Klouda PT, Bagshawe KD: The HL-A system in trophoblastic neoplasia. Lancet ii:834–837, 1971

    Google Scholar 

  339. Tatra G, Wolf E: Untersuchungen über Histokom-patibilitatsantigene und Trophoblasttumore. Arch Gynaekol 213:341–351, 1973

    CAS  Google Scholar 

  340. Mittal KK, Kachru RB, Brewer JI: The HL-A and ABO antigens in trophoblastic disease. Tissue Antigens 6:57–69, 1975

    PubMed  CAS  Google Scholar 

  341. Mogensen B, Kissmeyer-Nielsen F: Invasive mole, gestational choriocarcinoma and transplantation antigens. Ser Haemat 5:22–43, 1972

    CAS  Google Scholar 

  342. Lawler SD: HLA and trophoblastic tumours. Br Med Bull 34:305–308, 1978

    PubMed  CAS  Google Scholar 

  343. Lewis JL Jr, Terasaki PI: HL-A leukocyte antigen studies in women with gestational trophoblastic neoplasms. Am J Obstet Gynecol 111:547–554, 1971

    PubMed  Google Scholar 

  344. Rudolph RH,Thomas ED: Histocompatibility studies in patients with trophoblastic tumors. Am J Obstet Gynecol 108:1126–1129, 1976

    Google Scholar 

  345. Klouda PT, Lawler SD, Bagshawe KD: HL-A matings in trophoblastic neoplasia. Tissue Antigens 2:280–284, 1972 9. Bagshawe KD, Rawlings G, Pike MC, Lawler SD: ABO blood-groups in trophoblastic neoplasia. Lancet i:553–557, 1971

    Google Scholar 

  346. Amiel JL, Droz JP: Immunologie des tumeurs placentaires. J Gynecol Obstet Biol Reprod (Paris) 6:23–28, 1977

    CAS  Google Scholar 

  347. Shaw ARE, Dasgupta MK, Kovithavongs T, Johny KV, Leriche JC, Dossetor JB: Humoral and cellular immunity to paternal antigens in trophoblastic neoplasia. Int J Cancer 24:586–593, 1979

    PubMed  CAS  Google Scholar 

  348. Jones EA, Bodmer WF: Lack of expression of HLA antigens on choriocarcinoma cell lines. Tissue Antigens 16:195–202, 1980

    PubMed  CAS  Google Scholar 

  349. Tursz T, Lipinski M, Guillard M, Dutheil M, Bodmer JG, Amiel JL, et al.: Characterization of antibodies reacting with husband’s lymphocytes in sera from patients with trophoblastic malignancies. Tissue Antigens 17:376–385, 1981

    PubMed  CAS  Google Scholar 

  350. Patullo RA: Histocompatibility antigens in pregnancy, abortions, infertility, preeclampsia and trophoblast neoplasms. Am J Reproduct Immunol 1:29–34, 1980

    Google Scholar 

  351. Yamashita K, Wake N, Araki T, Ichinoe K, Kuroda M: A further HLA study of hydatidiform moles. Gynecol Oncol 11:23–28, 1981

    PubMed  CAS  Google Scholar 

  352. Honda J, Sato E, Ihara S, Munakata S, Sugawara N, Fukushima T: Pathogenetic study of complete and partial hydatidiform mole by HLA. Nippon Sanka Fujinka Gakkai Zasshi 34:83–88, 1982

    PubMed  CAS  Google Scholar 

  353. Lawler SD, Klouda PT, Bagshawe KD: The relationship between HLA antibodies and the causal pregnancy in choriocarcinoma. Br J Obstet Gynaecol 83:651–655, 1976

    PubMed  CAS  Google Scholar 

  354. Trowsdale J, Travers P, Bodmer WF, Patillo RA: Expression of HLA-A, -B, and -C and beta 2 microglobulin antigens in human choriocarcinoma cell lines. J Exp Med 152:11s–17s, 1980

    Google Scholar 

  355. Mittal KK, Kachru RB, Brewer JI: The HL-A and ABO antigens in trophoblastic disease. Tissue Antigens 6:57–69, 1975

    PubMed  CAS  Google Scholar 

  356. Tanimoto M, Takahashi T, Nishizuka Y: The expression of HLA on two cultured choriocarcinoma cell lines. Gann 73:27–34, 1983

    Google Scholar 

  357. Travers PJ, Arklie JL, Trowsdale J, Patillo RA, Bodmer WF: Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. Natl Cancer Inst Monogr 60:175–180, 1982

    PubMed  CAS  Google Scholar 

  358. Saleun JP, Youinou P, Le Goff P, Lemenn G, Morin JF: HLA antigen and monoclonal gammapa-thy. Tissue Antigens 13:233–235, 1979

    PubMed  CAS  Google Scholar 

  359. Youinou P: Genetic propensity to benignity in monoclonal-gammopathy. Acta Haematol 62:173–175, 1979

    PubMed  CAS  Google Scholar 

  360. Oosterhuis HJ, Feltkamp TEW, Van Rossum AL, Van Den Berg-Loonen PM, Nijenhuis LE: HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis. Ann NY Acad Sci 274:468–474, 1976

    PubMed  CAS  Google Scholar 

  361. Hiwatashi N, Kikuchi T, Masamune O, Ouchi E, Watanabe H, Goto Y: HLA antigens in colorectal cancers and adenomas. Tohoku J Exp Med 131:257–260, 1980

    PubMed  CAS  Google Scholar 

  362. Alcalay M, Bontoux D, Maire P, Matuchansky C, Alcalay D, Tanzer J: HLA-B27 and colorectal cancer. N Engl J Med 307:443–444, 1982

    PubMed  CAS  Google Scholar 

  363. Bertrams J, Kuweit E, Böhme U, Reis HE, Gallmeier WM, Wetter O, et al: HL-A antigens in Hodgkin’s disease and multiple myeloma. Tissue Antigens 2:41–46, 1972

    PubMed  CAS  Google Scholar 

  364. Smith G, Walford RL, Fishkin B, Carter PK, Tanaka K: HL-A phenotypes, immunoglobulins and k and X chains in multiple myeloma. Tissue Antigens 4:374–377, 1974

    PubMed  CAS  Google Scholar 

  365. Leech SH, Bryan CF, Elston RC, Rainey J, Bickers JN, Pelias MZ: Genetic studies in multiple myeloma. Cancer 51:1408–1411, 1983

    PubMed  CAS  Google Scholar 

  366. Miller WV: HL-A antigens and hematologic malignancy. Arch Intern Med 133:397–399, 1974

    PubMed  CAS  Google Scholar 

  367. Tananov AT, Kutyina RM, Turbina NS, Abakumov EM, Polyanskaya AM, Isaev VG, et al: HLA antigens in patients with blood pathology. Prob Gematol Pereliv Krovi 26:8–12, 1981

    CAS  Google Scholar 

  368. Van Camp BGK, Cole J, Peetermans ME: HLA antigens and homogeneous immunoglobulins. Clin Immun Immunopathol 7:315–318, 1977

    Google Scholar 

  369. Festen JJM, Marrink J, Kaars Sijpesteijn JA, Van Loghem E, Nijenhuis LE, Mandema E: A study on the association between myelomatosis and immunoglobulin allotypes, HLA, and blood groups. Immunogenetics 3:201–203, 1976

    Google Scholar 

  370. Mason DY, Cullen P: HL-A antigen frequencies in myeloma. Tissue Antigens 5:238–245, 1975

    PubMed  CAS  Google Scholar 

  371. Cassuto JP, Piereschi J, Maiolini R, Dujardin O, Ribeil R, Masseyeff R: Marqueurs HLA dans les myelomes et les dysglobulinemies monoclonales benignes. Nouv Presse Med 10:252–253, 1981

    PubMed  CAS  Google Scholar 

  372. Saleun JP, Youinou P, Le Goff P, Lemenn G, Morin JF: HLA antigen and monoclonal gammapathy. Tissue Antigens 13:233–235, 1979

    PubMed  CAS  Google Scholar 

  373. Ludwig H, Mayr W: Genetic aspects of susceptibility to multiple myeloma. Blood 59:1286–1291, 1982

    PubMed  CAS  Google Scholar 

  374. Jeannet M, Magnin C: HL-A antigens in haematological malignant diseases. Eur J Clin Invest 2:39–42, 1976

    Google Scholar 

  375. Smith G, Walford RL, Fishkin B: Antibody specificity for HL-A in human myeloma sera and immune rabbit sera. Tissue Antigens 4:595–600, 1974

    Google Scholar 

  376. Youinou P: Genetic propensity to benignity in monoclonal gammopathy. Acta Haematol 62:173–175, 1979

    PubMed  CAS  Google Scholar 

  377. Dick HM, Mackie R: Distribution of HLA antigens in patients with mycosis fungoides. Dermatologica 155:275–282, 1977

    PubMed  CAS  Google Scholar 

  378. Mackie R, Dick HM, De Sousa MB: HLA and mycosis fungoides. Lancet i: 1179, 1976

    Google Scholar 

  379. Tjernlund UM: Epidermal expression of HLA-DR antigens in mycosis fungoides. Arch Dermatol Res 261:81–86, 1978

    PubMed  CAS  Google Scholar 

  380. Amiel JL: Study of the leucocyte phenotypes in Hodgkin’s disease. In Curtoni ES, Mattiuz PL, Tosi RM (eds): Histocompatibility Testing 1967. Munksgaard, Copenhagen, 1967, pp 79–81

    Google Scholar 

  381. Sakurami T, Ueno Y, Iwaki Y, Park MS, Terasaki PI, Saji H: HLA-DR specificities among Japanese with several autoimmune disease. Tissue Antigens 19:129–133, 1982

    PubMed  CAS  Google Scholar 

  382. Welsh KI, Amlot P, Batchelor JR: Do alleles in linkage disequilibrium compensate for each other’s disadvantageous effects? Tissue Antigens 17:91–96, 1981

    PubMed  CAS  Google Scholar 

  383. Hornmark-Stenstam B, Landberg T, Low B: HLA antigens in Hodgkin’s disease of very long survival. Acta Radiol Oncol 17:283–288, 1978

    CAS  Google Scholar 

  384. Bjorkholm M, Holm G, Johansson B, Mellstedt H, Moller E: A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin’s disease. Tissue Antigens 6:247–256, 1975

    PubMed  CAS  Google Scholar 

  385. Forbes JF, Morris PJ: Analysis of HL-A antigens in patients with Hodgkin’s disease and their families. J Clin Invest 51:1156–1163, 1972

    PubMed  CAS  Google Scholar 

  386. Falk J, Osoba D: HL-A antigens and survival in Hodgkin’s disease. Lancet ii: 1118–1120, 1971

    Google Scholar 

  387. Bowers TK, Moldow CF, Bloomfield CD, Yunis EJ: Familial Hodgkin’s disease and the major histocompatibility complex. Vox Sang 33:273–277, 1977

    PubMed  CAS  Google Scholar 

  388. Dick FR, Fortuny I, Theologides A, Greally J, Wood N, Yunis E: HL-A and lymphoid tumors. Cancer Res 32:2608–2611, 1972

    PubMed  CAS  Google Scholar 

  389. Graff KS, Simon RM, Yankee RA, Devita VT, Rogentine CN: HL-A antigens in Hodgkin’s disease: Histopathologic and clinical correlations. J Natl Cancer Inst 52:1087–1090, 1974

    PubMed  CAS  Google Scholar 

  390. Falk J, Osoba D: The association of the human histocompatibility system with Hodgkin’s disease. J Immunogenet 1:53–61, 1974

    Google Scholar 

  391. Falk J, Osoba D: The HLA system and survival in malignant disease: Hodgkin’s disease and carcinoma of the breast. Prog Clin Biol Res 16:205–219, 1977

    PubMed  CAS  Google Scholar 

  392. Osoba D, Falk JA, Sousan P, Ciampi A, Till JE: The prognostic value of HLA phenotypes in Hodgkin’s disease. Cancer 46:1825–1832, 1980

    PubMed  CAS  Google Scholar 

  393. Sybesma JPHB, Holtzer JD, Borst-Eilers E, Moes M, Zegers BJM: Antibody response in Hodgkin’s disease and other lymphomas related to HL-A antigens, immunoglobulin levels and therapy. Vox Sang 25:254–262, 1973

    PubMed  CAS  Google Scholar 

  394. Sybesma JPHB: Antibody response related to HL-A antigens in Hodgkin’s disease and other lymphomas. Lancet ii:884, 1972

    Google Scholar 

  395. Nunez-Roldan A, Martinez-Guibelalde F, Gomez-Garcia P, Gomez-Pereira C, Nunez-Ollero G, Torres-Gomez A: Possible HLA role in a family with Hodgkin’s disease. Tissue Antigens 13:377–378, 1979

    PubMed  CAS  Google Scholar 

  396. Hors J, Steinberg G, Andrieu JM, Jacquillat C, Minev M, Messerschmitt T, et al.: HLA genotypes in familial Hodgkin’s disease: Excess of HLA identical affected sibs. Eur J Cancer 16:809–815, 1980

    PubMed  CAS  Google Scholar 

  397. Greene MH, McKeen EA, Li FP, Blattner WA, Fraumeni JF Jr: HLA antigens in familial Hodgkin’s disease. Int J Cancer 23:777–780, 1979

    PubMed  CAS  Google Scholar 

  398. Hors J, Dausset J: HLA and susceptibility to Hodgkin’s disease. Immunol Rev 70:167–192, 1983

    PubMed  CAS  Google Scholar 

  399. Berberich FR, Berberich MS, King MC, Engleman EG, Grumet FC: Hodgkin’s disease susceptibility: Linkage to the HLA locus demonstrated by a new concordance method. Hum Immunol 6:207–217, 1983

    PubMed  CAS  Google Scholar 

  400. Marshall WH, Barnard JM, Buehler SK, Crumley J, Larsen B: HLA in familial Hodgkin’s disease: Results and a new hypothesis. Int J Cancer 19:450–455, 1977

    PubMed  CAS  Google Scholar 

  401. Hors J, Dausset J: Maladies malignes identiques au sein d’une même famille. Nouv Presse Med 3:1237, 1974

    PubMed  CAS  Google Scholar 

  402. Torres A, Martinez F, Gomez P, Gomez C, Garcia JM, Nunez-Roldan A: Simultaneous Hodgkin’s disease in three siblings with identical HLA-genotype. Cancer 46:838–843, 1980

    PubMed  CAS  Google Scholar 

  403. McBride A, Fennelly JJ: Immunological depletion contributing to familial Hodgkin’s disease. Eur J Cancer 13:549–554, 1977

    PubMed  CAS  Google Scholar 

  404. Coukell A, Bodmer JG, Bodmer WF: HL-A types of 44 Hodgkin’s patients. Transplant Proc 3:1291–1295, 1971

    Google Scholar 

  405. Miller WV: HL-A antigens and hematologic malignancy. Arch Intern Med 133:397–399, 1974

    PubMed  CAS  Google Scholar 

  406. Terasaki PI, Perdue ST, Mickey MR: HLA frequencies in cancer: A second study. In Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, p 321

    Google Scholar 

  407. Henderson BE, Dworsky R, Menck H, Alena B, Henle W: Case-control study of Hodgkin’s disease. J Natl Cancer Inst 51:1443–1447, 1973

    PubMed  CAS  Google Scholar 

  408. Sybesma JPHB, Borst-Eilers E, Holtzer JD, Moes M, Pielage E, De Planque BA: HL-A antigens in Hodgkin’s disease and other lymphomas. Vox Sang 22:319–324, 1972

    PubMed  CAS  Google Scholar 

  409. Zervas JD, Delamore IW, Israels MCG: Leukocyte phenotyes in Hodgkin’s disease. Lancet ii:634–635, 1970

    Google Scholar 

  410. Moulinier MJ, Hoerni-Simon G, Merle MC, Mothey MC: Antigenes d’histocompitibilite et he-matosarcomes. Bordeaux Med 5:1285–1289, 1972

    CAS  Google Scholar 

  411. Richter KV, Fischer G, Menzel GR, Langfeld M, Aigte H, Ruckwarth G, et al.: HL-A Antigene und Disposition fur hamatologische maligne Erkrankungen. Haematologia 7:203–209, 1973

    PubMed  CAS  Google Scholar 

  412. Bertrams J, Kuwert E, Böhme U, Reis HE, Gallmeier WM, Wetter O, et al.: HL-A antigens in Hodgkin’s disease and multiple myeloma. Tissue Antigens 2:41–46, 1972

    PubMed  CAS  Google Scholar 

  413. Jeannet M, Magnin C: HL-A antigens in haemato-logical malignant diseases. Eur J Clin Invest 2:39–42, 1976

    Google Scholar 

  414. Kissmeyer-Nielsen F, Björn Jensen K, Ferrara GB, Kjerbye KE, Svejgaard A: HL-A phenotypes in Hodgkin’s disease preliminary report. Transplant Proc 3:1287–1289, 1971

    Google Scholar 

  415. Thorsby E, E’ngeset A, Lie SO: HL-A antigens and susceptibility to disease. Tissue Antigens 1:147–152, 1971

    PubMed  CAS  Google Scholar 

  416. Periin E, O’Donnell M: Another observation of increased frequency of HL-A5 and HL-A8 in Hodg-kin’s disease. Am J Clin Pathol 64:277–278, 1975

    Google Scholar 

  417. Harris R, Lawler SD, Oliver RTD: The HLA system in acute leukaemia and Hodgkin’s disease. Br Med Bull 34:301–304, 1978

    PubMed  CAS  Google Scholar 

  418. Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW: HL-A antigens in solid tumors. Cancer Res 33:648–650, 1973

    PubMed  CAS  Google Scholar 

  419. Jeannet M, Magnin C: HL-A antigens in malignant diseases. Transplant Proc 3:1301–1303, 1971

    Google Scholar 

  420. Fingold N: Critical analysis of relationships between HL-A system and susceptibility to disease. Transplant Proc 3:1317–1320, 1971

    Google Scholar 

  421. Bertrams J, Kuwert E, Gallmeier WM, Reis HE, Schmidt CG: Transient lymphocyte HL-A antigen “loss” in a case of irradiated M. Hodgkin. Tissue Antigens 1:105–108, 1971

    PubMed  CAS  Google Scholar 

  422. Forbes JF, Morris PJ: Leucocyte antigens in Hodgkin’s disease. Lancet ii:849–851, 1970

    Google Scholar 

  423. Bodmer WF: Genetic factors in Hodgkin’s disease: Association with a disease-susceptibility locus (DSA) in the HL-A region. Natl Cancer Inst Mon-ogr 36:127–134, 1973

    CAS  Google Scholar 

  424. Morris PJ, Ting A, Forbes JF: Further studies of HL-A. Transplant Proc 3:109–111, 1971

    PubMed  CAS  Google Scholar 

  425. Walford RL, Smith GS, Waters H: Histocompatibility systems and disease states with particular reference to cancer. Transplant Rev 7:78–111, 1971

    PubMed  CAS  Google Scholar 

  426. Kourilsky FM: Symposium international sur les relations entre les antigenes de tumeurs et les systemes d’histocompatibilite. Bull Cancer 58:315–324, 1977

    Google Scholar 

  427. Kadin ME: la-like (HLA-DR) antigens in the diagnosis of lymphoma and undifferentiated tumors. Arch Pathol Lab Med 104:503–508, 1980

    PubMed  CAS  Google Scholar 

  428. Pedersen-Bjergaard J, Philip P, Mortensen BT, Ersboll J, Jensen G, Panduro J, et al: Acute nonlym-phocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant disease. Blood 57:712–723, 1981

    PubMed  CAS  Google Scholar 

  429. Warren RP, Storb R, Nelson NJ, Sale GE, Thomas ED: Increased frequency of the group 5a antigen in patients with hematologic malignancies. Tissue Antigens 18:85–91, 1981

    PubMed  CAS  Google Scholar 

  430. Winchester R, Toguchi T, Szer I, Burmester G, Lo Galbo P, Cuttner J, et al: Association of susceptibility to certain hematopoietic malignancies with the presence of la allodeterminants distinct from the DR series. Immunol Rev 70:155–165, 1983

    PubMed  CAS  Google Scholar 

  431. Hors J: HLA and susceptibility to malignancies in humans. Bull Cancer (Paris) 69:199–207, 1982

    CAS  Google Scholar 

  432. Naeim F, Stoddard A, Smith GS, Walford RL: HL-A antigens on cells isolated from malignant and nonmalignant lymph nodes. Tissue Antigens 4:166–171, 1974

    PubMed  CAS  Google Scholar 

  433. De Moerloose PH, Jeannet M, Martin-Achard A, De Tribolet N, Seiler R, Guanella N: HLA and glioma. Tissue Antigens 12: 146–148, 1978

    PubMed  Google Scholar 

  434. Hirschberg H, Endresen L, Wikeby P: HLA antigens on glioma cells from short term cultures. Tissue Antigens 19:146–153, 1982

    PubMed  CAS  Google Scholar 

  435. May AG, Moss A, Gutierrez OH, Burday SZ, Campbell RG: Clinical study of pheochromocytoma. Am J Surg 141:346–352, 1981

    PubMed  CAS  Google Scholar 

  436. Simpson NE, Falk J: Exclusion of linkage between the loci for multiple endocrine neoplasia type-2 (MEN-2) and HLA. Hum Genet 60:157, 1982

    PubMed  CAS  Google Scholar 

  437. Majsky A, Abrahamova J, Koutecky J: Wilms’ tumor and HLA antigens. Tissue Antigens 11:74, 1978

    PubMed  CAS  Google Scholar 

  438. Abrahamova J, Majsky A, Fucikova T, Koutecky J: IGA-Immunglobuline und Antigen HLA-A1 beim Wilms-Tumor Bedeutung fur die Prognose der Erkrankung. Onkologie 1:177–179, 1978

    PubMed  CAS  Google Scholar 

  439. Abrahamova J, Majsky A, Koutecky J: HLA system U wilmsova nadoru a neuroblastomu. Cesk Pediatr 4:268–270, 1979

    Google Scholar 

  440. Abrahamova J, Majsky A, Koutecky J: Wilm’s tumour and the HL-A locus. Cas Lek Cesk 116: 1059–1061, 1977

    PubMed  CAS  Google Scholar 

  441. Abrahamova J, Majsky A, Fucikova T, Koutecky J, Strejcek J: Production of immunoglobins IgA and HLA antigen A: Significance for Wilms’ tumour progonosis. Cas Lek Cesk 117:667–669, 1978

    PubMed  CAS  Google Scholar 

  442. Majsky A, Abrahamova J: Pritomnost HLA-A2 anti-genu na lymfocytech: Ochrana pred vznikem nadoru? Cas Lek Cesk 119:47–50, 1980

    PubMed  CAS  Google Scholar 

  443. Majsky A, Abrahamova J: Schutzen die HLA-A2-Gene vor der Entwicklung eines Tumors? Eine Hypothese. Folia Haematol (Leipz) 108:90–96, 1981

    CAS  Google Scholar 

  444. Evers KG, Gutjahr P, Zschiedrich S, Haase W, Knoop U: Lack of association between HLA specificities and Wilms’ tumour. Eur J Pediatr 136:47–49, 1981

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for The Health Sciences, UCLA Tissue Typing Laboratory, 1000 Veterans Avenue, Los Angeles, California, USA

    Jawahar L. Tiwari Ph.D.

  2. UCLA Hospital and Clinics, Los Angeles, California, USA

    Paul I. Terasaki Ph.D. (Professor of Surgery)

Authors
  1. Jawahar L. Tiwari Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul I. Terasaki Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Tiwari, J.L., Terasaki, P.I. (1985). Malignancy. In: HLA and Disease Associations. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-8545-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-8545-5_12

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4613-8547-9

  • Online ISBN: 978-1-4613-8545-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation